secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardiff Oncology, Inc. (CRDF)
CIK:        0001213037
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001628280-23-022757
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardiff Oncology grants 40,032 stock options to new employee as inducement
--------------------------------------------------------------------------

- Non-qualified stock options to purchase 40,032 shares granted to one new employee on June 20, 2023.
- Exercise price of $1.56 per share equals closing price on grant date.
- Options vest over 4 years: 25% at 1-year anniversary, then monthly over remaining 36 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1213037/000162828023022757/0001628280-23-022757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1213037/000162828023022757/crdf-20230620.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-022757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer